Publication | Closed Access

3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

3,5-Dimethyl-4-isoxazoyl SelenocyanateAntiparasitic AgentMedicineParasitic ProtozoaLeishmania Infantum-infected MiceImmunologyPromising AgentPharmacologyVisceral LeishmaniasisDrug Discovery